Release Date: 13/02/15 09:47 Summary: Share Purchase Plan Price Sensitive: Yes Download Document 121.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%